BACKGROUND: In patients affected by hearth failure (HF) one of the major determinants of quality of life is functional limitation during effort. Oxygen uptake at peak exercise (VO2 peak) assessed through cardiopulmonary test (CPET) is nowadays a strong prognostic predictor in HF and it is also commonly used to monitor patients\u2019 functional status. As per present literature, a change of speed in left ventricular assistance device (LVAD) at rest causes a variation in CO, but is not related to better exercise capacity. In the present analysis, we tested the hypothesis that the change of pump speed during exercise in patients wearing LVAD might be associated with a better exercise performance. METHODS: We enrolled 16 HF patients (100% male...
AbstractBackgroundIn continuous-flow left ventricular assist device (LVAD) recipients, little is kno...
Peak cardiac power output (CPO), as a direct measurement of overall cardiac function, has been shown...
Aims Left ventricular assist device (LVAD) therapy is a promising option for patients with advanced...
Backgrounds Peak exercise cardiac output (CO) increase is associated with an increase of peak oxygen...
BACKGROUND: In patients affected by chronic heart failure (HF) an inappropriate tissues O2 extractio...
BACKGROUND: Increasing left ventricular assist device (LVAD) pump speed according to the patient's a...
Background. Increasing left ventricular assist device (LVAD) pump speed according to patients’ activ...
Patients supported with a left ventricular assist device (LVAD) have impaired cardiovascular adaptat...
AIMS: Although patients supported with a Continuous-Flow Left Ventricular Assist Device (CF-LVAD) ar...
BACKGROUND: The use of the HeartMate II continuous-flow left ventricular assist device (LVAD) improv...
© 2015 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantat...
Background Dyspnea is a pivotal symptom of chronic heart failure with reduced ejection fraction (HFr...
Low-output forward flow and impaired maximal exercise oxygen uptake (VO2 max) are hallmarks of patie...
Background Dyspnea is a pivotal symptom of chronic heart failure with reduced ejection fraction (HFr...
Background A reduced cardiac output (CO) response during exercise is a major limiting factor in hear...
AbstractBackgroundIn continuous-flow left ventricular assist device (LVAD) recipients, little is kno...
Peak cardiac power output (CPO), as a direct measurement of overall cardiac function, has been shown...
Aims Left ventricular assist device (LVAD) therapy is a promising option for patients with advanced...
Backgrounds Peak exercise cardiac output (CO) increase is associated with an increase of peak oxygen...
BACKGROUND: In patients affected by chronic heart failure (HF) an inappropriate tissues O2 extractio...
BACKGROUND: Increasing left ventricular assist device (LVAD) pump speed according to the patient's a...
Background. Increasing left ventricular assist device (LVAD) pump speed according to patients’ activ...
Patients supported with a left ventricular assist device (LVAD) have impaired cardiovascular adaptat...
AIMS: Although patients supported with a Continuous-Flow Left Ventricular Assist Device (CF-LVAD) ar...
BACKGROUND: The use of the HeartMate II continuous-flow left ventricular assist device (LVAD) improv...
© 2015 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantat...
Background Dyspnea is a pivotal symptom of chronic heart failure with reduced ejection fraction (HFr...
Low-output forward flow and impaired maximal exercise oxygen uptake (VO2 max) are hallmarks of patie...
Background Dyspnea is a pivotal symptom of chronic heart failure with reduced ejection fraction (HFr...
Background A reduced cardiac output (CO) response during exercise is a major limiting factor in hear...
AbstractBackgroundIn continuous-flow left ventricular assist device (LVAD) recipients, little is kno...
Peak cardiac power output (CPO), as a direct measurement of overall cardiac function, has been shown...
Aims Left ventricular assist device (LVAD) therapy is a promising option for patients with advanced...